Alginic acid/BSA is an antigen-adjuvant conjugate composed of Alginic acid and bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the generation of antigen-specific T cells.